Bipolar Disorder (January)

Date of Issue: 01/01/2011 | Volume: 9 | Number: 1

Issue Links:Learning Objectives | Editorial Information

Teaser to be posted soon.

In This Issue

Article

Using Lithium in Bipolar Disorder: A Primer

Topics: Bipolar Disorder

Currently, lithium is FDA approved for both acute mania and for maintenance bipolar treatment, but not for bipolar depression. Lithium is dirt-cheap and the size of its database for efficacy in bipolar disorder is unmatched by any other medication, although many of these studies are old.

Read More
Article

Discussing Bipolar Disorder with Your Patients

Topics: Bipolar Disorder

In my experience, there are five common reactions from patients with a new diagnosis of bipolar disorder, and here are some suggestions for how to respond constructively.

Read More
Expert QA

Distinguishing Bipolar from Unipolar Depression

Topics: Bipolar Disorder

Some patients complain bitterly about depression and dysphoria, but they don’t tell you anything about the other half of their lives—the upswings of mood and energy—so you may not realize the need to suspect bipolar illness.

Read More
Research Update

Vascular Depression? Not so Fast.

Topics: Depressive Disorder

More than a decade ago, researchers introduced the concept of “vascular depression,” a specific type of depression associated with cerebrovascular disease and loss of blood to the brain in older adults.

Read More
Research Update

Adjunctive Nuvigil Possibly Effective for Bipolar Depression

Topics: Bipolar Disorder | Depressive Disorder

The treatment of bipolar depression remains challenging. Only two medications are FDA approved for the condition—quetiapine (Seroquel) and olanzapine (Zyprexa)/fluoxetine (Prozac) combination—both of which cause weight gain and sedation, among other side effects.

Read More